Suspension of trading
Intellipharmaceutics International Inc. Stock
Stocks
I4AA
CA4581733090
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0445 EUR | -13.59% |
|
-.--% | - |
| Market Cap | 1.28M 1.12M 1.03M 958K 1.82M 122M 1.85M 12.39M 4.82M 60.01M 4.81M 4.71M 207M | P/E 2021 |
-0.4x | P/E 2022 | -0.91x |
|---|---|---|---|---|---|
| Enterprise Value | 3.52M 3.08M 2.84M 2.63M 5M 334M 5.08M 34.07M 13.25M 165M 13.23M 12.94M 570M | EV / Sales 2021 |
-
| EV / Sales 2022 | 74x |
| Free-Float |
98.24% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -13.59% |
| 3 years | 0.02 |  | 0.08 |
| 5 years | 0.01 | | 0.18 |
| 10 years | 0.01 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amina Odidi
DFI | Director of Finance/CFO | - | - |
| Comptroller/Controller/Auditor | - | 2007-03-31 | |
| Corporate Officer/Principal | - | 2014-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amina Odidi
BRD | Director/Board Member | - | 2004-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-02-13 | Option | Director | 100,000 | 0.3022% | ||
| 24-02-12 | Option | Director | 120,000 | 0.3626% | ||
| 24-02-12 | Option | Chief Executive Officer | 500,000 | 1.5109% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.59% | -.--% | -.--% | +27.14% | 1.52M | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,070B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 624B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| -2.58% | -2.07% | +27.62% | +22.57% | 328B | |
| +1.36% | +0.17% | +29.90% | +49.33% | 284B | |
| +1.98% | +4.08% | -25.78% | -39.02% | 217B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 198B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 161B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 135B | |
| Average | -0.59% | +1.69% | +24.24% | +50.84% | 346.75B | |
| Weighted average by Cap. | +1.50% | +1.84% | +41.85% | +87.34% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | 65.73K 57.52K 53.01K 49.13K 93.27K 6.24M 94.77K 636K 247K 3.08M 247K 241K 10.64M |
| Net income | -5.15M -4.5M -4.15M -3.85M -7.3M -488M -7.42M -49.76M -19.35M -241M -19.32M -18.9M -833M | -2.89M -2.53M -2.33M -2.16M -4.1M -275M -4.17M -27.97M -10.88M -135M -10.86M -10.62M -468M |
| Net Debt | 1.15M 1M 924K 856K 1.63M 109M 1.65M 11.08M 4.31M 53.65M 4.3M 4.21M 185M | 2.24M 1.96M 1.81M 1.68M 3.18M 213M 3.23M 21.68M 8.43M 105M 8.42M 8.24M 363M |
Employees
11
Sector
Pharmaceuticals
- Stock Market
- Stocks
- I4AA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
